NASHVILLE, Tenn. & PALO ALTO, Calif.–(BUSINESS WIRE)–Cognita Imaging, Inc. (Cognita), a wholly owned subsidiary of Mosaic Clinical Technologies, Inc. (Mosaic), has received a $1.29 million research contract from the U.S. Food and Drug Administration (FDA) to test a new way of evaluating AI-generated radiology reports. The contract took effect June 22, 2026, and will run for 18 months. The project, titled “Virtual Subject Matter Expert Agents for Radiology Report Evaluation,” focuses on a grow
See full post here as originally published on this site
